loading

Newamsterdam Pharma Company Nv Aktie (NAMS) Neueste Nachrichten

pulisher
Jun 04, 2025

Cantor Fitzgerald initiates overweight rating for NewAmsterdam Pharma stock - Investing.com

Jun 04, 2025
pulisher
Jun 04, 2025

Cantor Fitzgerald Initiates NewAmsterdam Pharma Overweight With $42 Price Target - marketscreener.com

Jun 04, 2025
pulisher
Jun 03, 2025

RBC Capital maintains outperform rating for NewAmsterdam Pharma stock By Investing.com - Investing.com South Africa

Jun 03, 2025
pulisher
Jun 03, 2025

RBC Capital maintains outperform rating for NewAmsterdam Pharma stock - Investing.com India

Jun 03, 2025
pulisher
May 31, 2025

Northern Trust Corp Takes $556,000 Position in NewAmsterdam Pharma (NASDAQ:NAMS) - Defense World

May 31, 2025
pulisher
May 30, 2025

NewAmsterdam Pharma (NASDAQ:NAMS) Rating Increased to Hold at Wall Street Zen - Defense World

May 30, 2025
pulisher
May 29, 2025

(NAMSW) Proactive Strategies - news.stocktradersdaily.com

May 29, 2025
pulisher
May 29, 2025

Shareholders Will Probably Not Have Any Issues With NewAmsterdam Pharma Company N.V.'s (NASDAQ:NAMS) CEO Compensation - simplywall.st

May 29, 2025
pulisher
May 27, 2025

NewAmsterdam Pharma to Participate at Upcoming Investor Conferences in June - The Manila Times

May 27, 2025
pulisher
May 27, 2025

NewAmsterdam Pharma CEO to Present at William Blair, Jefferies, and Goldman Sachs Healthcare Conferences - Stock Titan

May 27, 2025
pulisher
May 25, 2025

NewAmsterdam Pharma (NASDAQ:NAMS) Given Consensus Recommendation of “Buy” by Analysts - Defense World

May 25, 2025
pulisher
May 24, 2025

(NAMS) Technical Pivots with Risk Controls - news.stocktradersdaily.com

May 24, 2025
pulisher
May 23, 2025

NewAmsterdam Pharma’s SWOT analysis: obicetrapib stock poised for cardiovascular market By Investing.com - Investing.com South Africa

May 23, 2025
pulisher
May 23, 2025

NewAmsterdam Pharma’s SWOT analysis: obicetrapib stock poised for cardiovascular market - Investing.com Canada

May 23, 2025
pulisher
May 22, 2025

35,657 Shares in NewAmsterdam Pharma (NASDAQ:NAMS) Purchased by BNP Paribas Financial Markets - Defense World

May 22, 2025
pulisher
May 20, 2025

Financial Contrast: NewAmsterdam Pharma (NAMS) versus Its Rivals - Defense World

May 20, 2025
pulisher
May 19, 2025

(NAMSW) Investment Analysis - news.stocktradersdaily.com

May 19, 2025
pulisher
May 19, 2025

The Manufacturers Life Insurance Company Purchases New Position in NewAmsterdam Pharma (NASDAQ:NAMS) - Defense World

May 19, 2025
pulisher
May 15, 2025

Tower Research Capital LLC TRC Sells 6,485 Shares of NewAmsterdam Pharma (NASDAQ:NAMS) - Defense World

May 15, 2025
pulisher
May 14, 2025

Wall Street Analysts Predict a 132.5% Upside in NewAmsterdam Pharma Company N.V. (NAMS): Here's What You Should Know - MSN

May 14, 2025
pulisher
May 14, 2025

NewAmsterdam Pharma to Present at the 2025 RBCCM Global Healthcare Conference - GlobeNewswire

May 14, 2025
pulisher
May 14, 2025

NewAmsterdam Pharma Showcases Non-Statin CVD Pipeline at Major RBC Healthcare Conference - Stock Titan

May 14, 2025
pulisher
May 13, 2025

(NAMS) Proactive Strategies - news.stocktradersdaily.com

May 13, 2025
pulisher
May 13, 2025

Analysts Have Been Trimming Their NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS) Price Target After Its Latest Report - simplywall.st

May 13, 2025
pulisher
May 10, 2025

Barclays PLC Buys 9,117 Shares of NewAmsterdam Pharma (NASDAQ:NAMS) - Defense World

May 10, 2025
pulisher
May 10, 2025

Needham & Company LLC Issues Pessimistic Forecast for NewAmsterdam Pharma (NASDAQ:NAMS) Stock Price - Defense World

May 10, 2025
pulisher
May 09, 2025

NewAmsterdam Pharma Reports Q1 2025 Financial Results - TipRanks

May 09, 2025
pulisher
May 08, 2025

NewAmsterdam Pharma Q1 Net Loss Narrows, Revenue Rises - marketscreener.com

May 08, 2025
pulisher
May 08, 2025

NewAmsterdam Pharma Company NV reports results for the quarter ended March 31Earnings Summary - TradingView

May 08, 2025
pulisher
May 08, 2025

NewAmsterdam Pharma Company N.V. Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com

May 08, 2025
pulisher
May 08, 2025

NewAmsterdam Pharma Company N.V. (NAMS) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance

May 08, 2025
pulisher
May 08, 2025

NewAmsterdam Pharma Provides Corporate Update and Reports First Quarter Financial Results - GlobeNewswire

May 08, 2025
pulisher
May 08, 2025

Ratios Revealed: Decoding NewAmsterdam Pharma Company NV (NAMS)’s Financial Health - DWinneX

May 08, 2025
pulisher
May 08, 2025

Earnings Flash (NAMS) NewAmsterdam Pharma Co. NV Reports Q1 Revenue $2.98M, vs. FactSet Est of $1.6M - marketscreener.com

May 08, 2025
pulisher
May 08, 2025

Earnings Flash (NAMS) NewAmsterdam Pharma Co. NV Reports Q1 Revenue $3M, vs. FactSet Est of $1.6M - marketscreener.com

May 08, 2025
pulisher
May 08, 2025

NewAmsterdam Pharma Q1 2025 Financial Results and Corporate Update - TradingView

May 08, 2025
pulisher
May 08, 2025

Envestnet Asset Management Inc. Sells 8,738 Shares of NewAmsterdam Pharma (NASDAQ:NAMS) - Defense World

May 08, 2025
pulisher
May 07, 2025

NewAmsterdam Pharma Announces Late-Breaking Data from - GlobeNewswire

May 07, 2025
pulisher
May 07, 2025

NewAmsterdam Pharma (NAMS) Reveals Promising Phase 3 Study Results for Obicetrapib | NAMS Stock News - GuruFocus

May 07, 2025
pulisher
May 07, 2025

NewAmsterdam Pharma Presents Promising Phase 3 Trial Data - TipRanks

May 07, 2025
pulisher
May 07, 2025

NewAmsterdam Pharma Announces Late-Breaking Data from BROADWAY and TANDEM Pivotal Studies Published in Leading Medical Journals and Presented at the European Atherosclerosis Society (EAS) Congress 2025 - marketscreener.com

May 07, 2025
pulisher
May 03, 2025

Trend Tracker for (NAMS) - news.stocktradersdaily.com

May 03, 2025
pulisher
May 03, 2025

Brokerages Set NewAmsterdam Pharma (NASDAQ:NAMS) PT at $43.33 - Defense World

May 03, 2025
pulisher
May 02, 2025

NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

May 02, 2025
pulisher
May 02, 2025

NewAmsterdam Pharma Expands Clinical Team with 11 New Hires, Awards $4M in Equity Grants - Stock Titan

May 02, 2025
pulisher
May 01, 2025

Examining NewAmsterdam Pharma Company NV (NAMS) stock is warranted - uspostnews.com

May 01, 2025
pulisher
Apr 30, 2025

NewAmsterdam Pharma to Present New Clinical and Preclinical Data at 93rd EAS Congress - GlobeNewswire

Apr 30, 2025
pulisher
Apr 30, 2025

Major Breakthrough: NewAmsterdam Reveals Multiple Phase 3 Trial Results for Novel Heart Drug - Stock Titan

Apr 30, 2025
pulisher
Apr 30, 2025

Geode Capital Management LLC Raises Holdings in NewAmsterdam Pharma (NASDAQ:NAMS) - Defense World

Apr 30, 2025
pulisher
Apr 29, 2025

NewAmsterdam Pharma Company N.V. (NAMS): Among Billionaire Andreas Halvorsen’s Stock Picks With Huge Upside Potential - Insider Monkey

Apr 29, 2025
pulisher
Apr 29, 2025

Legal & General Group Plc Acquires 4,556 Shares of NewAmsterdam Pharma (NASDAQ:NAMS) - Defense World

Apr 29, 2025
$1.16
price up icon 0.00%
$573.50
price down icon 0.54%
$36.08
price up icon 15.90%
$305.31
price up icon 0.51%
$4.75
price up icon 3.70%
$484.93
price down icon 0.60%
Kapitalisierung:     |  Volumen (24h):